Patent · US Expired

Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof

US6511990B1 · kind B1 · utility

75Cited by
25References
35Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 24, 2000
Grant dateJan 28, 2003
Priority date
Expiry dateAug 24, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention provides the compound having the formula: wherein each of R1 and R2 is, substituted or unsubstituted, aryl, cycloalkyl, cycloalkylamino, naphtha, pyridineamino, piperidino, t-butyl, aryloxy, arylalkyloxy, or pyridine group; wherein A is an amido moiety, —O—, —S—, —NH—, or —CH2—; and wherein n is an integer from 3 to 8. The present invention also provides a method of selectively inducing growth arrest, terminal differentiation and/or apoptosis of neoplastic cells and thereby inhibiting proliferation of such cells. Moreover, the present invention provides a method of treating a patient having a tumor characterized by proliferation of neoplastic cells. Lastly, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically acceptable amount of the compound above.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.